Comprehensive review describes cannabis withdrawal occurring in half of regular users, with no approved medications for treatment

Cannabis withdrawal occurs in about half of regular users, typically starting 24-48 hours after cessation with symptoms peaking at days 2-6, and while supportive counseling is first-line treatment, no medications are specifically approved for it.

Connor, Jason P et al.·Addiction (Abingdon·2022·Moderate EvidenceReview
RTHC-03770ReviewModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Cannabis withdrawal occurs in approximately 50% of regular/dependent users. Symptoms begin 24-48 hours after cessation, peak at days 2-6, with some lasting 3+ weeks. Most common symptoms: anxiety, irritability, anger/aggression, sleep disturbance, depressed mood, appetite loss. No approved medications exist. Supportive counseling and psychoeducation are first-line. Promising pharmacological agents have been studied but findings are not replicated.

Key Numbers

Occurs in ~50% of regular users. Onset: 24-48 hours. Peak: days 2-6. Duration: up to 3+ weeks in heavy users. No approved medications.

How They Did This

Narrative review of the literature covering diagnosis, prevalence, course, and clinical management of cannabis withdrawal.

Why This Research Matters

Cannabis withdrawal is clinically significant because symptoms often precipitate relapse. Understanding its course and management options is essential for anyone attempting to quit.

The Bigger Picture

As cannabis potency increases and more people become regular users, withdrawal is becoming a more common clinical challenge. The lack of approved pharmacotherapy represents a significant gap in addiction medicine.

What This Study Doesn't Tell Us

Narrative review, not systematic. Pharmacological trial evidence is limited and underpowered. Cannabis agonist use is off-label. Withdrawal severity likely varies by product potency and duration of use.

Questions This Raises

  • ?Would gradual tapering of THC products reduce withdrawal severity?
  • ?Are higher-potency products associated with worse withdrawal?
  • ?Could CBD mitigate withdrawal symptoms?

Trust & Context

Key Stat:
~50% of regular users experience withdrawal; no approved medications
Evidence Grade:
Comprehensive narrative review of a well-characterized phenomenon, though pharmacotherapy evidence is limited.
Study Age:
Published in 2022.
Original Title:
Clinical management of cannabis withdrawal.
Published In:
Addiction (Abingdon, England), 117(7), 2075-2095 (2022)
Database ID:
RTHC-03770

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does cannabis withdrawal feel like?

The most common symptoms are anxiety, irritability, anger or aggression, sleep problems (including vivid dreams), depressed mood, and loss of appetite. Less common physical symptoms include chills, headaches, sweating, and stomach pain.

How long does cannabis withdrawal last?

Symptoms typically start within 24-48 hours of quitting, peak between days 2-6, and most resolve within 2-3 weeks. However, some symptoms can persist longer in heavy users.

Read More on RethinkTHC

Cite This Study

RTHC-03770·https://rethinkthc.com/research/RTHC-03770

APA

Connor, Jason P; Stjepanović, Daniel; Budney, Alan J; Le Foll, Bernard; Hall, Wayne D. (2022). Clinical management of cannabis withdrawal.. Addiction (Abingdon, England), 117(7), 2075-2095. https://doi.org/10.1111/add.15743

MLA

Connor, Jason P, et al. "Clinical management of cannabis withdrawal.." Addiction (Abingdon, 2022. https://doi.org/10.1111/add.15743

RethinkTHC

RethinkTHC Research Database. "Clinical management of cannabis withdrawal." RTHC-03770. Retrieved from https://rethinkthc.com/research/connor-2022-clinical-management-of-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.